Managers / Q3 2021 · view latest →
LITTLEJOHN & CO LLC
CIK 0001042537 · 8 SOUND SHORE DR, SUITE 303, GREENWICH, CT, 06830 · 2035523532
Summary
Littlejohn & Co LLC reported $348M in U.S.-listed holdings across 206 positions for Q3 2021.
Its largest position, GMS1EUR, represents 9.6% of the portfolio.
Compared with Q2 2021, the fund opened 9 new positions and exited 16.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 60.8% · $212M
- Other · 21.5% · $75M
- REIT · 8.2% · $29M
- ETP · 6.7% · $23M
- Ltd Part · 1.5% · $5M
- Other · 1.3% · $4M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TALOTALOS ENERGY INC | NEW | +593.6K | 593.6K | +$8M | $8M |
| ATENTO S A | NEW | +97.6K | 97.6K | +$3M | $3M |
| CWCURTISS WRIGHT CORP | NEW | +21.5K | 21.5K | +$3M | $3M |
| HSIHEIDRICK & STRUGGLES INTL IN | NEW | +530.0K | 530.0K | +$967,000 | $967,000 |
| KELYAKELLY SVCS INC | NEW | +775.0K | 775.0K | +$111,000 | $111,000 |
| EFFECTOR THERAPEUTICS INC | NEW | +16.7K | 16.7K | +$27,000 | $27,000 |
| LUMIRADX LIMITED | NEW | +19.6K | 19.6K | +$23,000 | $23,000 |
| LIDRWAEYE INC | NEW | +16.7K | 16.7K | +$19,000 | $19,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $106M | 18 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $192M | 20 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $198M | 20 | Nov 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $210M | 21 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $192M | 24 | May 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $198M | 23 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $198M | 25 | Nov 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $196M | 30 | Aug 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $156M | 35 | May 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $143M | 36 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $118M | 44 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $144M | 52 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $167M | 61 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $167M | 67 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $192M | 98 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $277M | 166 | Aug 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $381M | 174 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $384M | 175 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $348M | 206 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $340M | 214 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $378M | 150 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.